Designing viral clearance studies for CGT products according to ICH Q5A (R2): part 2

Watch the video or view the poster for: An evaluation of process steps that can be utilized for gene therapy products A better understanding of how to apply prior knowledge to your viral clearance process A step-by-step overview of performing platform validation

Please enter your email to access content Read now